2026 NPPES data Cytopathology Physician NPI 1730390725 MD
Verify on CMS →

MARY HANNA, MD

Cytopathology Physician in BALDWIN PARK, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 143 beneficiaries · Cytopathology Physician avg: 92
Generic prescribing
82%
generic claims · 18% brand-name · higher generic rates reduce patient out-of-pocket costs
What the federal data reveals: MARY HANNA, MD is a Cytopathology Physician ([object Object]) practicing in BALDWIN PARK, California with a Medicare Part D prescribing footprint of 2K claims across 143 beneficiaries — 18% brand-name prescribing .

What stands out: MARY HANNA, MD filed 2,211 Medicare Part D claims in 2023 across BALDWIN PARK, California. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board-eligible specialty (heuristic — not verified)

MARY HANNA, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

MARY HANNA, MD at a glance

Quality data not reported

NPI registry status

Active

Issued 05/24/2007

NPI 1730390725

Primary specialty

Cytopathology Physician

Niche

1,383 US NPIs in this specialty

Medicare Part D claims

2,211 2303% vs specialty avg

2023 prescription claims

Specialty avg: 92

Specialty distribution in California

How Cytopathology Physician compares to other specialties among California providers

California providers

Cytopathology Physician share within California

1. Cytopathology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Cytopathology Physician share within California

Specialty board-certification context

Estimated specialty board-certified rate — Cytopathology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Cytopathology Physician ABMS/AOA estimate

Est. board-certified rate (Cytopathology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Cytopathology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARY HANNA, MD is a Cytopathology Physician provider practicing in BALDWIN PARK, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1730390725. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MARY HANNA, MD appears in the CMS NPPES registry as a Cytopathology Physician provider holding MD credentials at 1011 BALDWIN PARK BLVD, BALDWIN PARK, CA, 91706, with a listed phone of (626) 851-5938. NPI 1730390725 was issued on 05/24/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what HANNA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 2,211 prescription claims written by this provider, covering 143 Medicare beneficiaries and totaling roughly $204K in drug spend, split 18% brand-name and 82% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Cytopathology Physician is a narrow specialty nationwide, with 1,383 enrolled providers across 50 states and an average of 92 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1011 BALDWIN PARK BLVD
BALDWIN PARK, CA 91706

Provider Details

NPI 1730390725
Specialty Cytopathology Physician
Credentials MD
Gender Female
NPI Issued 05/24/2007

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to MARY HANNA, MD. To verify MARY HANNA, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

MARY HANNA, MD — brand share 18.0%
Specialty average (est.)

18% brand-name claims vs 82% generic, on 2,211 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,211
Total Claims
$204K
Total Drug Cost
143
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,264
Total Day Supply
65,765
Brand vs Generic
18% brand / 82% generic
Brand Drug Cost
$166K
Generic Drug Cost
$38K

Patient Demographics

Average Patient Age
80.5 years
Avg HCC Risk Score
2.54
Gender Split
60% female / 40% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Levothyroxine Sodium
162
Tamsulosin Hcl
109
Atorvastatin Calcium
105
Metformin Hcl
93
Lisinopril
63
Albuterol Sulfate Hfa
Albuterol Sulfate
51
Amlodipine Besylate
47
Donepezil Hcl
43
Losartan Potassium
43
Finasteride
42

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Cytopathology Physician Overview

How MARY HANNA, MD fits within the Cytopathology Physician landscape nationally.

1,383
Cytopathology Physician Providers in US
50
States with Cytopathology Physician
92
Avg Claims per Provider

MARY HANNA, MD's 2,211 claims are above the specialty average of 92.

Nearby Cytopathology Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as HANNA.

Compare Cytopathology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARY HANNA, MD's specialty?
MARY HANNA, MD specializes in Cytopathology Physician and practices in BALDWIN PARK, California. Credentials: MD.
How much does MARY HANNA, MD prescribe under Medicare Part D?
In 2023, MARY HANNA, MD wrote 2,211 Medicare Part D claims totaling $204K in drug costs for 143 beneficiaries.
Where is MARY HANNA, MD located?
MARY HANNA, MD is located at 1011 BALDWIN PARK BLVD, BALDWIN PARK, CA, 91706. Phone: (626) 851-5938.
What is MARY HANNA, MD's NPI number?
MARY HANNA, MD's National Provider Identifier (NPI) is 1730390725, issued on 05/24/2007.
Does MARY HANNA, MD prescribe more brand-name or generic drugs?
MARY HANNA, MD's prescribing is 18% brand-name and 82% generic drugs by claim count, with $166K in brand drug costs.
How many Cytopathology Physician providers are there in the US?
There are 1,383 Cytopathology Physician providers across 50 states in the US. The average Cytopathology Physician provider writes 92 Medicare Part D claims per year.
What drugs does MARY HANNA, MD prescribe most often?
Based on 2023 Medicare Part D data, MARY HANNA, MD's most frequently prescribed drugs include Levothyroxine Sodium, Tamsulosin Hcl, Atorvastatin Calcium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARY HANNA, MD accept Medicare?
MARY HANNA, MD appears in CMS Medicare data with 2,211 Part D claims and 143 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARY HANNA, MD's credentials?
MARY HANNA, MD's NPI is 1730390725 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology